Literature DB >> 32320062

Infection risk in a gastroenterological ward during a nosocomial COVID-19 infection event.

Tasuku Hara1,2, Chie Yamamoto2,3, Ryo Sawada3, Tomoya Ohara1, Kohei Oka1, Naoto Iwai1, Yutaka Inada1, Toshifumi Tsuji1, Takashi Okuda1, Toshiyuki Komaki1, Keizo Kagawa1.   

Abstract

Entities:  

Keywords:  COVID-19; digestive disease; hospital-acquired infection; infection control; nosocomial SARS-CoV-2

Mesh:

Year:  2020        PMID: 32320062      PMCID: PMC7264652          DOI: 10.1002/jmv.25853

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   20.693


× No keyword cloud information.
To the Editor, The reported rate of severe cases and the case‐fatality rate for coronavirus disease (COVID‐19) is high among patients with comorbidities and the elderly, but few reports have been published on the infection risk. After a health care professional working in the gastroenterological ward at this hospital contracted COVID‐19, a case of possibly nosocomial COVID‐19 was identified. This report describes a study on the risk of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection among patients hospitalized with gastrointestinal disorders when health care workers implement appropriate measures to prevent contact and droplet transmission. This retrospective study was conducted with the approval of the Institutional Ethics Review Board. Polymerase chain reaction (PCR) testing was carried out for 87 patients who were hospitalized during the period when a health care professional was suspected to have contracted the active infection at the workplace from February to March 2020, in Fukuchiayma City Hospital gastroenterological ward. The clinical characteristics of the study patients are shown in Table 1.
Table 1

Characteristics of the study population

Clinical characteristics of the study patients (n = 87)
Age, median (range), y70 (21‐94)
Male sex, n (%)50 (57.5)
Current smoker, n (%)25 (28.7)
Immunosuppressant use, n (%)16 (18.4)
Primary disease, n (%)
Cancer39 (44.8)
Liver cirrhosis5 (5.7)
Chronic hepatitis5 (5.7)
Cholangitis, cholecystitis10 (11.5)
Pancreatitis5 (5.7)
Gastrointestinal bleeding6 (6.9)
Ileus5 (5.7)
Peritonitis4 (4.6)
Other digestive disorders8 (9.2)
Coexisting disorder, n (%)
Chronic obstructive pulmonary disease11 (12.6)
Diabetes mellitus21 (24.1)
Hypertension37 (42.5)
Coronary heart disease14 (16.1)
Chronic renal failure3 (3.4)
Age‐adjusted Charlson Comorbidity Index
0‐538 (43.7)
613 (14.9)
712 (13.8)
85 (5.7)
≥919 (21.8)
Exposure category
Low30 (34.5)
Medium50 (57.5)
High7 (8.0)
Characteristics of the study population To assess the risk of COVID‐19 infection, the risk‐exposure category and underlying conditions and their relationship with a positive PCR result were examined. Risk‐exposure categories, which based on whether patients and health care professionals use personal protective equipment, were assessed using interim US guidance for risk assessment and public health management for health care personnel exposure in health care setting to patients with 2019 novel coronavirus. Health care professionals wore a surgical mask while working and removed the mask during breaks. Not all patients wore surgical masks. The age‐adjusted Charlson Comorbidity Index (CCI), a method of predicting mortality by classifying or weighting comorbid conditions and age, was used to assess the effect of underlying conditions on exposure risk. Only 1 of 87 patients (1.1%) tested positive on PCR for COVID‐19. The patient was almost asymptomatic. The patient who tested positive for COVID‐19 was in the medium‐risk exposure category with a CCI of 8 and had decompensated cirrhosis. The basic reproduction number (R0: the number of people a single patient is expected to infect) for COVID‐19 is estimated at 2.2 (1.4‐3.9). In the present study, low rates of SARS‐CoV‐2 infection were observed among patients. During the peri‐infection period, because the study center was in an influenza‐endemic area, health care professionals at the hospital were obligated to wear a surgical mask and instructed to be diligent with handwashing. Surgical masks are reported to prevent transmission of coronaviruses. These measures to prevent contact and droplet transmission were considered to have been practised adequately and were relatively successful at preventing nosocomial infection. The CCI is used as a prognostic indicator and to determine treatment strategies for gastroenterological diseases. , Therefore, the CCI was used in this study to assess the risk conferred by underlying diseases for COVID‐19. The patient who tested positive for SARS‐CoV‐2 was given a high CCI of 8. Elderly patients and patients with many comorbidities are considered at risk of SARS‐CoV‐2 infection. No patient in the low‐risk exposure category or with high‐risk underlying conditions was infected with SARS‐CoV‐2 at this hospital. Therefore, appropriate implementation of measures against contact and droplet transmission appear adequate to minimize nosocomial spread are of utmost importance in preventing COVID‐19 transmission.

CONFLICT OF INTERESTS

The authors declare they no conflict of interests.
  6 in total

1.  Impact of the Charlson comorbidity index and prognostic nutritional index on prognosis in patients with early gastric cancer after endoscopic submucosal dissection.

Authors:  Naoto Iwai; Osamu Dohi; Yuji Naito; Yutaka Inada; Akifumi Fukui; Shun Takayama; Kazuyuki Ogita; Kei Terasaki; Takahiro Nakano; Tomohiro Ueda; Tetsuya Okayama; Naohisa Yoshida; Kazuhiro Katada; Kazuhiro Kamada; Kazuhiko Uchiyama; Takeshi Ishikawa; Osamu Handa; Tomohisa Takagi; Hideyuki Konishi; Nobuaki Yagi; Yoshito Itoh
Journal:  Dig Endosc       Date:  2018-04-11       Impact factor: 7.559

2.  Optimal treatment strategy for acute cholecystitis based on predictive factors: Japan-Taiwan multicenter cohort study.

Authors:  Itaru Endo; Tadahiro Takada; Tsann-Long Hwang; Kohei Akazawa; Rintaro Mori; Fumihiko Miura; Masamichi Yokoe; Takao Itoi; Harumi Gomi; Miin-Fu Chen; Yi-Yin Jan; Chen-Guo Ker; Hsiu-Po Wang; Seiki Kiriyama; Keita Wada; Hiroki Yamaue; Masaru Miyazaki; Masakazu Yamamoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2017-05-31       Impact factor: 7.027

3.  Validation of a combined comorbidity index.

Authors:  M Charlson; T P Szatrowski; J Peterson; J Gold
Journal:  J Clin Epidemiol       Date:  1994-11       Impact factor: 6.437

4.  Respiratory virus shedding in exhaled breath and efficacy of face masks.

Authors:  Nancy H L Leung; Daniel K W Chu; Eunice Y C Shiu; Kwok-Hung Chan; James J McDevitt; Benien J P Hau; Hui-Ling Yen; Yuguo Li; Dennis K M Ip; J S Malik Peiris; Wing-Hong Seto; Gabriel M Leung; Donald K Milton; Benjamin J Cowling
Journal:  Nat Med       Date:  2020-04-03       Impact factor: 53.440

5.  Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia.

Authors:  Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng
Journal:  N Engl J Med       Date:  2020-01-29       Impact factor: 176.079

6.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

  6 in total
  3 in total

1.  A Simplified "One-Pathway" Protocol for the Transformation of General Wards to Infectious Disease Wards Upon the Pandemic Outbreak.

Authors:  Jikai Yin; Dongdong Li; Meijuan Peng; Wangang Guo
Journal:  Front Public Health       Date:  2022-06-24

2.  What do we know about SARS-CoV-2 transmission? A systematic review and meta-analysis of the secondary attack rate and associated risk factors.

Authors:  Wee Chian Koh; Lin Naing; Liling Chaw; Muhammad Ali Rosledzana; Mohammad Fathi Alikhan; Sirajul Adli Jamaludin; Faezah Amin; Asiah Omar; Alia Shazli; Matthew Griffith; Roberta Pastore; Justin Wong
Journal:  PLoS One       Date:  2020-10-08       Impact factor: 3.240

3.  Healthcare-associated COVID-19 in England: A national data linkage study.

Authors:  Alex Bhattacharya; Simon M Collin; James Stimson; Simon Thelwall; Olisaeloka Nsonwu; Sarah Gerver; Julie Robotham; Mark Wilcox; Susan Hopkins; Russell Hope
Journal:  J Infect       Date:  2021-08-30       Impact factor: 6.072

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.